Insider Cluster (3 insiders) ·Filed Jul 7, 2026

SION

Sionna Therapeutics, Inc.
BEARISH
Impact 5/10
Horizondays Processed2mo ago
Insider cluster: 3 insiders, $11.0M total
Actionable Insight ▼ Bearish

The identical director sales signal a possible secondary offering or lockup expiration — watch for an S-1 filing or 8-K disclosure. With 82% analyst bullish consensus and a $1.9B market cap, the selling may create short-term pressure, but the historical ineffectiveness of insider sell signals on SION (several prior short calls missed) suggests fading the move. Monitor for any concurrent corporate filings.

DirectionBearish
Confidencemedium
Horizondays
Final — all horizons settled through T+60d
SION ▼ -88.41% at T+60d
SHORT call ✓ call won +88.41% · α vs SPY +90.90% · entry $44.00 → $5.10
Entry anchored
Jul 7, 03:59 PM ET
via exchange tick
T+1d
+2.14%
call -2.14% · α -1.29%
$44.94
settled 3mo ago
T+5d
-3.20%
call +3.20% · α +4.07%
$42.59
settled 3mo ago
T+20d
+7.59%
call -7.59% · α -4.32%
$47.34
settled 8w ago
T+60d
-88.41%
call +88.41% · α +90.90%
$5.10
settled 2d ago

Price Chart

Loading chart...

Executive Summary

Three Sionna Therapeutics insiders sold a combined $10.99M in shares over a 7-day window, including two directors who each sold $5.27M at $45.50. The total represents 0.58% of the $1.9B market cap. While insider selling is a weaker signal than buying, the identical size and timing of the director sales suggest a planned distribution, potentially a secondary offering or lockup expiration.

Key Financial Metrics

Direction
selling
Total Value
$11.0M
Insiders
3

Key Facts

  • Total insider sales of $10.99M over 7 days, or ~0.58% of market cap
  • OrbiMed Advisors LLC (Director) sold 115.8K shares at $45.50 for $5.27M on 2026-06-30
  • Director Peter A. Thompson sold 115.8K shares at $45.50 for $5.27M on 2026-06-30
  • Chief Legal Officer Jennifer Fitzpatrick sold 10.3K shares at $43.60 for $447K on 2026-07-06, following option exercises

Financial Impact

Insider sales totaling $10.99M, equivalent to 0.58% of market cap

insider holdingsfree float

Risk Factors

  • Further insider selling or a registered secondary offering could increase supply
  • The CLO's sale after option exercise is routine, but two directors selling identical amounts raises the risk of a block trade

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
82% bullish (17 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-SION-1783456867164
16 reports for SION
Performance horizon
83% Hit rate 5 of 6 directional calls best @ T+60▲ +84.72%May 29, 2026
Filters
Rows
Reports for SION — sortable, filterable
TypeNow
Aug 10, 2026
7w ago
8-K
BEARISH ★ 7/10
$4.50 $7.30▼ −62.22%▼ −63.14%$5.04 (−12.00%)
Aug 6, 2026
8w ago
8-K
NEUTRAL ★ 4/10
$49.61 $6.75▼ −86.39%▼ −86.99%$5.04 (−89.84%)
Jul 9, 2026
12w ago
Insider Cluster
NEUTRAL ★ 4/10
$45.29 $51.04▲ +12.70%▲ +10.27%$5.04 (−88.87%)
Jul 9, 2026
12w ago
Insider Cluster
BEARISH ★ 5/10
$45.29 $51.04▼ −12.70%▼ −10.27%$5.04 (+88.87%)
Jul 7, 2026
12w ago
Insider Cluster
BEARISH ★ 5/10
$44.00 $47.34▼ −7.59%▼ −4.32%$5.04 (+88.55%)
Jul 2, 2026
13w ago
Insider Cluster
NEUTRAL ★ 4/10
$43.99 $46.78▲ +6.34%▲ +6.76%$5.04 (−88.54%)
Jun 11, 2026
16w ago
Institutional Cluster
NEUTRAL ★ 4/10
$36.05 $44.94▲ +24.66%▲ +22.77%$5.04 (−86.02%)
May 30, 2026
17w ago
Insider Cluster
NEUTRAL ★ 2/10
$40.90 $43.99▲ +7.55%▲ +8.85%$5.04 (−87.68%)
May 29, 2026
17w ago
144
BEARISH ★ 6/10
$40.90 $43.99▼ −7.55%▼ −8.85%$5.04 (+87.68%)
May 12, 2026
20w ago
8-K
NEUTRAL ★ 5/10
$40.94 $34.03▼ −16.88%▼ −15.15%$5.04 (−87.69%)
Showing 10 of 16

US Market Status

Market Open — Closes in 3h 55m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Jul 7, 2026